Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nu-Med PlusNUMD Market Cap is $1.27 Mil as of Jul. 22, 2026. The stock has 1 warning sign investors should review. Among 864 Medical Devices & Instruments companies, Nu-Med Plus ranks worse than 97.92% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nu-Med Plus's share price for the quarter that ended in Mar. 2026 was $0.011. Nu-Med Plus's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 83.55 Mil. Therefore, Nu-Med Plus's market cap for the quarter that ended in Mar. 2026 was $0.92 Mil.
Nu-Med Plus's quarterly market cap
declined
from Sep. 2025 ($2.61 Mil) to Dec. 2025 ($1.44 Mil) and
declined
from Dec. 2025 ($1.44 Mil) to Mar. 2026 ($0.92 Mil).
Nu-Med Plus's annual market cap
declined
from Dec. 2023 ($3.38 Mil) to Dec. 2024 ($1.28 Mil) but then
increased
from Dec. 2024 ($1.28 Mil) to Dec. 2025 ($1.44 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nu-Med Plus's Enterprise Value for Today is $1.49 Mil.
Nu-Med Plus (OTCPK:NUMD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nu-Med Plus Market Cap Related Terms
Nu-Med Plus Market Cap Historical Data
* Premium members only.
The historical data trend for Nu-Med Plus's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nu-Med Plus's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nu-Med Plus Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's Market Cap distribution charts can be found below:
* The bar in red indicates where Nu-Med Plus's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nu-Med Plus's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nu-Med Plus (NUMD) has a Market Cap of $1.27 Mil as of Jul. 22, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nu-Med Plus and its competitors. According to the industry distribution chart, Nu-Med Plus ranks #846 out of 864 companies in the Medical Devices & Instruments industry, placing it in the top 97.9%.
Is Nu-Med Plus' Market Cap too high?
Nu-Med Plus' current Market Cap is $1.27 Mil. The Medical Devices & Instruments industry median Market Cap is 112.18. Nu-Med Plus' value of $1.27 Mil is 98.9% below this industry median. Based on the distribution chart, Nu-Med Plus ranks #846 out of 864 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Nu-Med Plus' Market Cap compare to SSKN and ODYY?
According to the Medical Devices & Instruments industry distribution chart, Nu-Med Plus ranks #846 out of 864 companies for Market Cap. This places Nu-Med Plus in the lower half of its industry. The industry median Market Cap is 112.18. Nu-Med Plus' value of $1.27 Mil is 98.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 112.18, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nu-Med Plus's current Market Cap of $1.27 Mil is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nu-Med Plus and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 112.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nu-Med Plus's current Market Cap is $1.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nu-Med Plus stock overvalued right now?
Nu-Med Plus (NUMD) has a current Market Cap of $1.27 Mil. The current Market Cap is $1.27 Mil and 98.9% below the Medical Devices & Instruments industry median of 112.18. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nu-Med Plus (NUMD), the current Market Cap is $1.27 Mil as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nu-Med Plus Inc is a medical device company engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems, and the medical community throughout the world. It is currently working to locate a merger partner that will be able to fund the final development of these products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUMD has been successfully added to your 
